Over 4 Years of Safety and Efficacy with Voxelotor Treatment for Patients with Sickle Cell Disease: Updated Results from an Open-Label Extension of the Phase 3 HOPE TrialMaureen Okam Achebe,Hoda M. A. Hassab,Salam Al-Kindi,Clark Brown,Paul Telfer,Bart J. Biemond,Thokozeni Lipato, Mark Davis,Sarah Gray,Victor R. GordeukBLOOD(2023)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要